ÂÜÀòÂÒÂ×

Hanna P. Lesch is currently serving as the Chief Technology Officer at EXOTHERA in Belgium. Prior to this role, she held positions such as Gene Therapy Unit Director at Kuopio Center for Gene and Cell Therapy, Research and Development Director at FinVector Oy, and Research Director at FKD Therapies. She has a strong background in gene therapy, process development of viral vectors, and extensive experience in the field. Hanna has also completed her Doctor of Philosophy in Molecular Medicine from the University of Eastern Finland, where she also obtained her Master's degree in Biotechnology.